FDA lists 205 molecular targets for pediatric cancer research
To help with anti-cancer drug development, the FDA has developed two new lists of molecular targets to guide submissions for pediatric study plans.
The two …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
